UPDATE: Warfarin Genetic Testing Decreases Hospitalization Rate, Study Finds | GenomeWeb

This article has been updated to include comments from the ACC meeting.

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Genetic testing for variants related to warfarin treatment response decreased hospitalization rates by almost one third in a prospective study of patients at sites across the country, according to research being presented today at the American College of Cardiology's scientific session in Atlanta.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Pacific Biosciences is hosting a competition in which researchers are vying to win free sequencing for an organism with the most interesting genome.

An opinion piece appearing in Newsday likens familial DNA searches to stop-and-frisk policies.

The San people of Africa have drawn up a code of conduct for researchers, according to the Conversation.

In Nature this week: genotypes linked to hip osteoarthritis, and more.